IBRX vs REGN: Which Stock is Better?
Side-by-side comparison of Immunitybio Inc and Regeneron Pharmaceuticals Inc in 2026
IBRX
Immunitybio Inc
$8.20
REGN
Regeneron Pharmaceuticals Inc
$749.41
Key Metrics Comparison
| Metric | IBRX | REGN | Winner |
|---|---|---|---|
| Market Cap | $7.95B | $79.35B | REGN |
| P/E Ratio | N/A | 18.08 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | 4.1% | 0.0% | IBRX |
| Gross Margin | 99.3% | 44.6% | IBRX |
Analyze IBRX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IBRX or REGN a better investment?
Comparing IBRX and REGN: Immunitybio Inc has a market cap of $7.95B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IBRX and REGN?
IBRX (Immunitybio Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IBRX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IBRX or REGN?
IBRX has higher revenue growth at 4.1% vs 0.0% for REGN.
Which company is more profitable: IBRX or REGN?
Immunitybio Inc (IBRX) has higher gross margins at 99.3% compared to 44.6% for REGN.
Which is the larger company: IBRX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $7.95B for IBRX.
Should I buy IBRX or REGN in 2026?
Both IBRX and REGN have investment merit. IBRX trades at $8.20 while REGN trades at $749.41. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IBRX and REGN stock?
Key differences: Market Cap ($7.95B vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (4.1% vs 0.0%), Gross Margin (99.3% vs 44.6%).